204 related articles for article (PubMed ID: 34493595)
1. Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme.
Lopes-Ramos CM; Belova T; Brunner TH; Ben Guebila M; Osorio D; Quackenbush J; Kuijjer ML
Cancer Res; 2021 Nov; 81(21):5401-5412. PubMed ID: 34493595
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.
Mei J; Cai Y; Xu R; Yang X; Zhou W; Wang H; Liu C
Technol Cancer Res Treat; 2021; 20():15330338211011970. PubMed ID: 33955303
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
[TBL] [Abstract][Full Text] [Related]
4. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
Huang R; Lu X; Sun X; Wu H
Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
[No Abstract] [Full Text] [Related]
5. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
7. Correlation of immune phenotype with IDH mutation in diffuse glioma.
Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M
Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme.
Feng L; Qian H; Yu X; Liu K; Xiao T; Zhang C; Kuang M; Cheng S; Li X; Wan J; Zhang K
Sci Rep; 2017 Jul; 7(1):6968. PubMed ID: 28761058
[TBL] [Abstract][Full Text] [Related]
9. Gene co-expression network construction and analysis for identification of genetic biomarkers associated with glioblastoma multiforme using topological findings.
Redekar SS; Varma SL; Bhattacharjee A
J Egypt Natl Canc Inst; 2023 Jul; 35(1):22. PubMed ID: 37482563
[TBL] [Abstract][Full Text] [Related]
10. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types.
Paré L; Pascual T; Seguí E; Teixidó C; Gonzalez-Cao M; Galván P; Rodríguez A; González B; Cuatrecasas M; Pineda E; Torné A; Crespo G; Martin-Algarra S; Pérez-Ruiz E; Reig Ò; Viladot M; Font C; Adamo B; Vidal M; Gaba L; Muñoz M; Victoria I; Ruiz G; Viñolas N; Mellado B; Maurel J; Garcia-Corbacho J; Molina-Vila MÁ; Juan M; Llovet JM; Reguart N; Arance A; Prat A
Ann Oncol; 2018 Oct; 29(10):2121-2128. PubMed ID: 30165419
[TBL] [Abstract][Full Text] [Related]
11. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
Dreyfuss JM; Johnson MD; Park PJ
Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
[TBL] [Abstract][Full Text] [Related]
14. HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma.
Yu M; Yu S; Zhou W; Yi B; Liu Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):108293. PubMed ID: 34763232
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Han Z; Jia J; Lv Y; Wang R; Cao K
Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.
Rutledge WC; Kong J; Gao J; Gutman DA; Cooper LA; Appin C; Park Y; Scarpace L; Mikkelsen T; Cohen ML; Aldape KD; McLendon RE; Lehman NL; Miller CR; Schniederjan MJ; Brennan CW; Saltz JH; Moreno CS; Brat DJ
Clin Cancer Res; 2013 Sep; 19(18):4951-60. PubMed ID: 23864165
[TBL] [Abstract][Full Text] [Related]
17. Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.
Steed TC; Treiber JM; Taha B; Engin HB; Carter H; Patel KS; Dale AM; Carter BS; Chen CC
J Neurooncol; 2020 Jul; 148(3):455-462. PubMed ID: 32556864
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis to Identify Genes Associated with Stemness and Immune Infiltration in Glioblastoma.
Warrier NM; Agarwal P; Kumar P
Cells; 2021 Oct; 10(10):. PubMed ID: 34685742
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
20. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
[Next] [New Search]